Shannyn A. Smith, MBA
About Shannyn A. Smith, MBA
Shannyn excels at business transformation. Most recently, she drove the transformation of Xilio Therapeutics into a public company. As the Founder of The Capital Boutique, she connects female founders in STEMM and female funders, including accelerators, angel investors, and venture investors, to increase access to capital. Shannyn is an Innovator in Residence at the MIT Innovation Initiative. Her research explores how lack of gender diversity of Limited Partners’ investment leadership reinforces lack of gender diversity of General Partners of venture funds. In 2021, Shannyn was honored as one of the Boston Business Journal's Power 50: The Movement Makers. Prior to start-ups and biotech, Shannyn led the relaunch of a rare disease brand – the only product in the hematology portfolio addressing women’s health – at Takeda Pharmaceuticals. She was named Takeda’s “Marketer of the Year” and recognized by PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) as one of the most influential people in the healthcare industry. Shannyn launched her career in strategic communications and consulting in NYC. She built and led business units and teams focused on early commercialization, scientific and medical strategy, and US and Global product launches for pharmaceutical and biotech clients in the areas of immunology, immuno-oncology, and oncology. Shannyn earned her MBA from the MIT Sloan School of Management and her AB, cum laude, from Harvard University.